d-Fenfluramine and d-norfenfluramine hypophagias do not require increased hypothalamic 5-hydroxytryptamine release

Eur J Pharmacol. 1994 Oct 13;264(1):111-5. doi: 10.1016/0014-2999(94)90646-7.

Abstract

d-Fenfluramine (2.5 mg/kg i.p.) caused marked hypophagia in food-deprived rats and significantly increased medial hypothalamic extracellular 5-hydroxytryptamine (5-HT) as indicated by in vivo microdialysis. When the drug was given after the 5-HT synthesis inhibitor p-chlorophenylalanine (150 mg/kg per day x 3) the hypophagic response was unimpaired but dialysate 5-HT concentration no longer rose. The d-fenfluramine metabolite d-norfenfluramine (1.5 mg/kg i.p.) caused slightly greater hypophagia than the parent drug and completely blocked feeding in animals pretreated with p-chlorophenylalanine, but dialysate 5-HT was increased in neither circumstance. The results provide evidence against mediation of the hypophagic effects of d-fenfluramine and d-norfenfluramine by increased availability of 5-HT to receptors.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Eating
  • Feeding and Eating Disorders / chemically induced*
  • Feeding and Eating Disorders / metabolism
  • Fenclonine / pharmacology
  • Fenfluramine / pharmacology*
  • Hypothalamus / drug effects
  • Hypothalamus / metabolism*
  • Male
  • Microdialysis
  • Norfenfluramine / pharmacology*
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, Serotonin / metabolism
  • Serotonin / metabolism*

Substances

  • Receptors, Serotonin
  • Norfenfluramine
  • Fenfluramine
  • Serotonin
  • Fenclonine